insulinsecreting

Insulinsecreting refers to cells or tissues that synthesize and release insulin, a peptide hormone essential for regulating blood glucose. The primary insulinsecreting cells are the beta cells of the pancreatic islets of Langerhans, which constitute the majority of endocrine cells in the islets. In healthy individuals, pancreatic beta cells respond to rising blood glucose by secreting insulin into the portal circulation, helping to maintain normoglycemia.

Beta-cell secretion of insulin is triggered by glucose sensing and signaling. Glucose uptake and metabolism in beta cells increase the ATP/ADP ratio, leading to closure of ATP‑sensitive potassium channels, membrane depolarization, and opening of voltage-gated calcium channels. The resulting calcium influx triggers exocytosis of insulin-containing secretory granules. Insulin release is modulated by incretin hormones such as GLP-1 and GIP, by autonomic inputs, and by nutrient signals including amino acids and fatty acids. Insulinsecreting activity is tightly regulated to meet fluctuating peripheral demands.

Beyond beta cells, other endocrine cells in the islets secrete related hormones (such as glucagon from alpha cells and somatostatin from delta cells), but insulinsecreting predominantly refers to beta cells. Insulin acts primarily on liver, muscle, and adipose tissue to promote glucose uptake and storage, suppress hepatic glucose production, and coordinate overall energy metabolism. Clinically, loss or dysfunction of insulinsecreting beta cells underpins type 1 diabetes, while beta-cell dysfunction contributes to type 2 diabetes. Rare tumors, such as insulinomas, arise from insulinsecreting cells and cause hypoglycemia.

In research and therapy, efforts focus on restoring or replacing insulinsecreting function, including stem-cell–derived beta-like cells and islet transplantation, as potential treatments for diabetes.